4mq2

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Current revision (16:40, 20 September 2023) (edit) (undo)
 
(3 intermediate revisions not shown.)
Line 1: Line 1:
-
{{STRUCTURE_4mq2| PDB=4mq2 | SCENE= }}
 
-
===The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor===
 
-
{{ABSTRACT_PUBMED_24239188}}
 
-
==Disease==
+
==The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor==
-
[[http://www.uniprot.org/uniprot/DYR1A_HUMAN DYR1A_HUMAN]] Defects in DYRK1A are the cause of mental retardation autosomal dominant type 7 (MRD7) [MIM:[http://omim.org/entry/614104 614104]]. A disease characterized by primary microcephaly, severe mental retardation without speech, anxious autistic behavior, and dysmorphic features, including bitemporal narrowing, deep-set eyes, large simple ears, and a pointed nasal tip. Mental retardation is characterized by significantly below average general intellectual functioning associated with impairments in adaptative behavior and manifested during the developmental period.<ref>PMID:21294719</ref>
+
<StructureSection load='4mq2' size='340' side='right'caption='[[4mq2]], [[Resolution|resolution]] 2.80&Aring;' scene=''>
 +
== Structural highlights ==
 +
<table><tr><td colspan='2'>[[4mq2]] is a 4 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4MQ2 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4MQ2 FirstGlance]. <br>
 +
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 2.8&#8491;</td></tr>
 +
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=1PE:PENTAETHYLENE+GLYCOL'>1PE</scene>, <scene name='pdbligand=2C4:METHYL+4-CHLORO-3-{[(2-METHOXY-7-OXO-7,8-DIHYDROPYRIDO[2,3-D]PYRIMIDIN-6-YL)CARBONYL]AMINO}BENZOATE'>2C4</scene>, <scene name='pdbligand=PTR:O-PHOSPHOTYROSINE'>PTR</scene>, <scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr>
 +
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4mq2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4mq2 OCA], [https://pdbe.org/4mq2 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4mq2 RCSB], [https://www.ebi.ac.uk/pdbsum/4mq2 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4mq2 ProSAT]</span></td></tr>
 +
</table>
 +
== Disease ==
 +
[https://www.uniprot.org/uniprot/DYR1A_HUMAN DYR1A_HUMAN] Defects in DYRK1A are the cause of mental retardation autosomal dominant type 7 (MRD7) [MIM:[https://omim.org/entry/614104 614104]. A disease characterized by primary microcephaly, severe mental retardation without speech, anxious autistic behavior, and dysmorphic features, including bitemporal narrowing, deep-set eyes, large simple ears, and a pointed nasal tip. Mental retardation is characterized by significantly below average general intellectual functioning associated with impairments in adaptative behavior and manifested during the developmental period.<ref>PMID:21294719</ref>
 +
== Function ==
 +
[https://www.uniprot.org/uniprot/DYR1A_HUMAN DYR1A_HUMAN] May play a role in a signaling pathway regulating nuclear functions of cell proliferation. Phosphorylates serine, threonine and tyrosine residues in its sequence and in exogenous substrates.<ref>PMID:8769099</ref>
 +
<div style="background-color:#fffaf0;">
 +
== Publication Abstract from PubMed ==
 +
DYRK1B is a kinase over-expressed in certain cancer cells (including colon, ovarian, pancreatic, etc.). Recent publications have demonstrated inhibition of DYRK1B could be an attractive target for cancer therapy. From a data-mining effort, the team has discovered analogues of pyrido[2,3-d]pyrimidines as potent enantio-selective inhibitors of DYRK1B. Cells treated with a tool compound from this series showed the same cellular effects as down regulation of DYRK1B with siRNA. Such effects are consistent with the proposed mechanism of action. Progress of the SAR study is presented.
-
==Function==
+
Pyrido[2,3-d]pyrimidines: Discovery and preliminary SAR of a novel series of DYRK1B and DYRK1A inhibitors.,Anderson K, Chen Y, Chen Z, Dominique R, Glenn K, He Y, Janson C, Luk KC, Lukacs C, Polonskaia A, Qiao Q, Railkar A, Rossman P, Sun H, Xiang Q, Vilenchik M, Wovkulich P, Zhang X Bioorg Med Chem Lett. 2013 Dec 15;23(24):6610-5. doi: 10.1016/j.bmcl.2013.10.055., Epub 2013 Nov 1. PMID:24239188<ref>PMID:24239188</ref>
-
[[http://www.uniprot.org/uniprot/DYR1A_HUMAN DYR1A_HUMAN]] May play a role in a signaling pathway regulating nuclear functions of cell proliferation. Phosphorylates serine, threonine and tyrosine residues in its sequence and in exogenous substrates.<ref>PMID:8769099</ref>
+
-
==About this Structure==
+
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
-
[[4mq2]] is a 4 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4MQ2 OCA].
+
</div>
-
 
+
<div class="pdbe-citations 4mq2" style="background-color:#fffaf0;"></div>
-
==Reference==
+
== References ==
-
<ref group="xtra">PMID:024239188</ref><references group="xtra"/><references/>
+
<references/>
-
[[Category: Dual-specificity kinase]]
+
__TOC__
-
[[Category: Garvie, C.]]
+
</StructureSection>
-
[[Category: Janson, C A.]]
+
[[Category: Homo sapiens]]
-
[[Category: Liang, L.]]
+
[[Category: Large Structures]]
-
[[Category: Lukacs, C M.]]
+
[[Category: Garvie C]]
-
[[Category: Dyrk1a]]
+
[[Category: Janson CA]]
-
[[Category: Dyrk1b]]
+
[[Category: Liang L]]
-
[[Category: Kinase]]
+
[[Category: Lukacs CM]]
-
[[Category: Transferase-transferase inhibitor complex]]
+

Current revision

The crystal structure of DYRK1a with a bound pyrido[2,3-d]pyrimidine inhibitor

PDB ID 4mq2

Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/4mq2"
Personal tools